These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 16651362

  • 1. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
    Dani C, Bertini G, Simone P, Rubaltelli FF.
    Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
    [No Abstract] [Full Text] [Related]

  • 2. [Hypertrophic cardiomyopathy in a low-birth-weight newborn treated with dexamethasone].
    Villa Alcázar M, Pellicer Martínez A, Burgueros Valero M, Quero Jiménez J.
    An Esp Pediatr; 1996 Apr; 44(4):393-4. PubMed ID: 8796947
    [No Abstract] [Full Text] [Related]

  • 3. [Transient hypertrophic cardiomyopathy due to dexamethasone therapy in a premature infant].
    Pokela ML.
    Duodecim; 1995 Apr; 111(14):1310-3. PubMed ID: 9244681
    [No Abstract] [Full Text] [Related]

  • 4. Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.
    Ohning BL, Fyfe DA, Riedel PA.
    Am Heart J; 1993 Jan; 125(1):253-6. PubMed ID: 8417533
    [No Abstract] [Full Text] [Related]

  • 5. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL, American Academy of Pediatrics. Committee on Fetus and Newborn.
    Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
    [Abstract] [Full Text] [Related]

  • 6. Postnatal glucocorticoids in very preterm infants: "the good, the bad, and the ugly"?
    Thébaud B, Lacaze-Masmonteil T, Watterberg K.
    Pediatrics; 2001 Feb; 107(2):413-5. PubMed ID: 11158479
    [No Abstract] [Full Text] [Related]

  • 7. Reversible steroid-induced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns.
    Haney I, Lachance C, van Doesburg NH, Fouron JC.
    Am J Perinatol; 1995 Jul; 12(4):271-4. PubMed ID: 7575834
    [Abstract] [Full Text] [Related]

  • 8. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.
    Brand PL, van Lingen RA, Brus F, Talsma MD, Elzenga NJ.
    Acta Paediatr; 1993 Jul; 82(6-7):614-7. PubMed ID: 8339005
    [Abstract] [Full Text] [Related]

  • 9. Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review.
    Fritz KI, Bhat AM.
    J Perinatol; 1998 Jul; 18(1):38-44. PubMed ID: 9527943
    [Abstract] [Full Text] [Related]

  • 10. Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease.
    Yates HL, Newell SJ.
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F190-4. PubMed ID: 21115554
    [Abstract] [Full Text] [Related]

  • 11. Dexamethasone given to premature infants and cardiac diastolic function in early childhood.
    Wong IH, Digby AM, Warren AE, Pepelassis D, Vincer M, Chen RP.
    J Pediatr; 2011 Aug; 159(2):227-31. PubMed ID: 21397911
    [Abstract] [Full Text] [Related]

  • 12. Postnatal corticosteroids for preterm infants--do what we say, not what we do.
    Jobe AH.
    N Engl J Med; 2004 Mar 25; 350(13):1349-51. PubMed ID: 15044647
    [No Abstract] [Full Text] [Related]

  • 13. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience.
    Röhr SB, Sauer H, Gortner L, Gräber S, Meyer S.
    Acta Paediatr; 2013 Oct 25; 102(10):e436. PubMed ID: 23819647
    [No Abstract] [Full Text] [Related]

  • 14. Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia.
    Kewitz G, Wudel S, Hopp H, Hopfenmüller W, Vogel M, Roots I.
    J Perinat Med; 2008 Oct 25; 36(4):359-64. PubMed ID: 18598128
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppressive drugs and hypertrophic cardiomyopathy.
    Brand PL, Brus F.
    Lancet; 1995 Jun 24; 345(8965):1644. PubMed ID: 7540240
    [No Abstract] [Full Text] [Related]

  • 16. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
    Cogo PE, Simonato M, Mariatoffolo G, Stefanutti G, Chierici M, Cobelli C, Ori C, Carnielli VP.
    Pediatr Res; 2008 Apr 24; 63(4):433-7. PubMed ID: 18356753
    [Abstract] [Full Text] [Related]

  • 17. [Glucocorticoid-induced hypertrophic cardiomyopathy in premature infants: apropos of 4 cases].
    Boeuf B, Maragnes P, Belzic I, Lacotte J, Bonte JB, Guillois B.
    Arch Pediatr; 1997 Feb 24; 4(2):152-7. PubMed ID: 9097827
    [Abstract] [Full Text] [Related]

  • 18. [Secondary myocardial hypertrophy in a very small premature infant treated with dexamethasone].
    Korsch E, Gillor A, Groneck P, Bläker F.
    Monatsschr Kinderheilkd; 1993 Feb 24; 141(2):112-5. PubMed ID: 8459811
    [Abstract] [Full Text] [Related]

  • 19. Dexamethasone and bronchopulmonary dysplasia.
    Frank L, Lecuona PC.
    Pediatrics; 1996 Sep 24; 98(3 Pt 1):514-5. PubMed ID: 8784386
    [No Abstract] [Full Text] [Related]

  • 20. Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
    Kale Y, Aydemir O, Ceylan O, Bas AY, Demirel N.
    Pediatr Neonatol; 2015 Aug 24; 56(4):268-70. PubMed ID: 23639746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.